Theseus Pharmaceuticals (THRX) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for Theseus Pharmaceuticals (NASDAQ:THRX)

Current
Institutional Ownership
Percentage
91.05%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$42.26M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$2.10M
Get THRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theseus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

THRX Institutional Buying and Selling by Quarter

Theseus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Frazier Life Sciences Management L.P.2,118,051$8.58M0.5%-5.8%4.789%
2/15/2024Beryl Capital Management LLC288,887$1.17M0.6%N/A0.653%
2/14/2024ADAR1 Capital Management LLC174,715$708K0.3%N/A0.395%
2/13/2024Tower Research Capital LLC TRC 9,302$38K0.0%+62.2%0.021%
2/12/2024MMCAP International Inc. SPC277,303$1.12M0.2%N/A0.627%
2/12/2024Highbridge Capital Management LLC616,860$2.50M0.1%N/A1.395%
2/6/2024AJOVista LLC9,520$39K0.0%N/A0.022%
2/2/2024 BML Capital Management LLC1,108,320$4.49M3.4%N/A2.506%
1/30/2024 BML Capital Management LLC1,108,317$4.49M3.5%N/A2.506%
1/30/2024Strs Ohio46,300$187K0.0%+1,614.8%0.105%
1/19/2024 Denali Advisors LLC103,800$420K0.1%-18.8%0.235%
1/12/2024SG Americas Securities LLC13,212$54K0.0%N/A0.030%
1/5/2024 Exchange Traded Concepts LLC48,510$196K0.0%+34.0%0.110%
11/15/2023Laurion Capital Management LP171,157$460K0.0%-4.7%0.393%
11/15/2023Affinity Asset Advisors LLC400,726$1.08M0.3%+66.8%0.919%
11/14/2023Lynx1 Capital Management LP702,415$1.89M1.2%-7.2%1.611%
11/13/2023Foresite Capital Management V LLC4,108,796$11.05M17.6%+14.6%9.424%
11/13/2023Acadian Asset Management LLC259,470$696K0.0%N/A0.595%
11/8/2023Forefront Analytics LLC17,672$48K0.0%N/A0.041%
10/27/2023TD Asset Management Inc213,896$575K0.0%+100.0%0.491%
10/20/2023 Denali Advisors LLC127,900$344K0.1%+675.2%0.293%
10/18/2023 Exchange Traded Concepts LLC36,210$97K0.0%+144.8%0.083%
8/21/2023Affinity Asset Advisors LLC240,244$2.24M0.8%+144.6%0.551%
8/15/2023HighVista Strategies LLC136,719$1.28M0.6%N/A0.314%
8/14/2023Driehaus Capital Management LLC232,693$2.17M0.0%+2.9%0.534%
8/8/2023Candriam S.C.A.270,015$2.52M0.0%-16.6%0.620%
8/7/2023Principal Financial Group Inc.10,679$100K0.0%N/A0.025%
8/2/2023Bank of Montreal Can277,074$2.80M0.0%N/A0.636%
7/20/2023 Exchange Traded Concepts LLC14,791$138K0.0%N/A0.034%
7/18/2023 Denali Advisors LLC16,500$154K0.1%N/A0.038%
5/16/2023Fairmount Funds Management LLC1,865,671$16.57M2.8%N/A4.281%
5/16/2023Altium Capital Management LP112,614$1M0.6%N/A0.258%
5/16/2023Boxer Capital LLC350,000$3.11M0.2%-15.7%0.803%
5/15/2023Affinity Asset Advisors LLC98,221$872K0.3%N/A0.225%
5/10/2023Tekla Capital Management LLC75,000$666K0.0%-25.0%0.172%
5/3/2023Jump Financial LLC15,859$141K0.0%N/A0.036%
2/14/2023Boxer Capital LLC415,000$2.07M0.1%-53.5%1.072%
2/13/2023Foresite Capital Management V LLC3,585,346$17.86M13.9%+7.5%9.262%
2/10/2023Opaleye Management Inc.535,000$2.66M0.9%+142.5%1.382%
2/3/2023Frazier Life Sciences Management L.P.1,398,194$6.96M0.4%N/A3.612%
Move Your Money Before May 1 (Ad)

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1. 
11/15/2022Farallon Capital Management LLC223,149$1.29M0.0%-45.5%0.576%
11/14/2022Forefront Analytics LLC13,065$74K0.0%N/A0.034%
8/16/2022Woodline Partners LP211,684$1.17M0.0%-15.3%0.547%
8/16/2022DAFNA Capital Management LLC81,899$453K0.1%+2.2%0.212%
8/15/2022Opaleye Management Inc.32,300$179K0.1%N/A0.083%
8/12/2022Ensign Peak Advisors Inc142,598$788K0.0%-43.0%0.368%
8/8/2022Walleye Capital LLC31,719$175K0.0%N/A0.082%
8/4/2022TD Asset Management Inc.106,948$591K0.0%+59.3%0.276%
5/10/2022TD Asset Management Inc.67,133$774K0.0%+19.4%0.173%
5/5/2022New York State Common Retirement Fund9,495$109K0.0%+475.1%0.025%
2/19/2022Woodline Partners LP250,000$3.17M0.0%N/A0.646%
2/15/2022Laurion Capital Management LP205,021$2.60M0.0%N/A0.530%
2/15/2022Lynx1 Capital Management LP409,358$5.19M4.5%N/A1.058%
2/15/2022Adage Capital Partners GP L.L.C.761,589$9.66M0.0%N/A1.968%
2/14/2022Boxer Capital LLC892,057$11.31M0.4%N/A2.305%
2/14/2022Nextech Invest AG611,310$7.75M1.8%N/A1.579%
2/14/2022DAFNA Capital Management LLC97,500$1.24M0.3%N/A0.252%
2/14/2022Omega Fund Management LLC711,479$9.02M1.3%N/A1.838%
2/11/2022Foresite Capital Opportunity Management V LLC468,820$5.95M4.0%N/A1.211%
2/11/2022Ensign Peak Advisors Inc250,000$3.17M0.0%N/A0.646%
2/10/2022TD Asset Management Inc.56,202$713K0.0%N/A0.145%
2/8/2022Northern Trust Corp96,884$1.23M0.0%N/A0.250%
1/24/2022Strs Ohio2,700$34K0.0%N/A0.007%
(Data available from 1/1/2016 forward)

THRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of THRX shares?

During the previous two years, 37 institutional investors and hedge funds held shares of Theseus Pharmaceuticals. The most heavily invested institutionals were Fairmount Funds Management LLC ($16.57M), Foresite Capital Management V LLC ($11.05M), Frazier Life Sciences Management L.P. ($8.58M), BML Capital Management LLC ($4.49M), Boxer Capital LLC ($3.11M), Bank of Montreal Can ($2.80M), and Opaleye Management Inc. ($2.66M).Learn more on THRX's institutional investors.

What percentage of Theseus Pharmaceuticals stock is owned by institutional investors?

91.05% of Theseus Pharmaceuticals stock is owned by institutional investors. Learn more on THRX's institutional investor holdings.

Which institutional investors have been buying Theseus Pharmaceuticals stock?

Of the 29 institutional investors that purchased Theseus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.22M), Fairmount Funds Management LLC ($1.87M), Frazier Life Sciences Management L.P. ($1.40M), Foresite Capital Management V LLC ($773.45K), Highbridge Capital Management LLC ($616.86K), Affinity Asset Advisors LLC ($400.73K), and Opaleye Management Inc. ($346.65K).

How much institutional buying is happening at Theseus Pharmaceuticals?

Institutional investors have bought a total of 9,654,079 shares in the last 24 months. This purchase volume represents approximately $52.91M in transactions.

Which Theseus Pharmaceuticals major shareholders have been selling company stock?

Of the 10 institutional investors that sold Theseus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Boxer Capital LLC ($542.06K), Farallon Capital Management LLC ($186.57K), Frazier Life Sciences Management L.P. ($130.14K), Ensign Peak Advisors Inc ($107.40K), Lynx1 Capital Management LP ($54.59K), Candriam S.C.A. ($53.80K), and Woodline Partners LP ($38.32K).

How much institutional selling is happening at Theseus Pharmaceuticals?

Institutional investors have sold a total of 1,170,443 shares in the last 24 months. This volume of shares sold represents approximately $6.36M in transactions.


This page (NASDAQ:THRX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners